Octavio Marquez - May 12, 2022 Form 4 Insider Report for DIEBOLD NIXDORF, Inc (DBD)

Role
President and CEO, Director
Signature
Jonathan B. Leiken, Attorney-in-fact for Octavio Marquez
Stock symbol
DBD
Transactions as of
May 12, 2022
Transactions value $
$110,637
Form type
4
Date filed
5/12/2022, 10:32 AM
Previous filing
Mar 16, 2022
Next filing
Feb 1, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DBD Common Shares Purchase $48.6K +21.5K +7.76% $2.26* 298K May 12, 2022 Direct F1
transaction DBD Common Shares Purchase $12.1K +5.37K +1.8% $2.25* 304K May 12, 2022 Direct F1
transaction DBD Common Shares Purchase $46.6K +20.4K +6.72% $2.28* 324K May 12, 2022 Direct F1
transaction DBD Common Shares Purchase $3.41K +1.5K +0.46% $2.27* 326K May 12, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding DBD Non-Qualified Stock Option 15.9K May 12, 2022 Common Shares 15.9K $34.13 Direct F2
holding DBD Non-Qualified Stock Option 22.7K May 12, 2022 Common Shares 22.7K $32.33 Direct F2
holding DBD Non-Qualified Stock Option 16.4K May 12, 2022 Common Shares 16.4K $27.39 Direct F2
holding DBD Non-Qualified Stock Option 38K May 12, 2022 Common Shares 38K $26.60 Direct F3
holding DBD Non-Qualified Stock Option 19.8K May 12, 2022 Common Shares 19.8K $18.75 Direct F3
holding DBD Non-Qualified Stock Option 33.8K May 12, 2022 Common Shares 33.8K $4.08 Direct F3
holding DBD Non-Qualified Stock Option 9.33K May 12, 2022 Common Shares 9.33K $11.96 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Number includes restricted stock units.
F2 Granted under the 1991 Equity and Performance Incentive Plan; option is generally exercisable in annual increments of 1/3, 1/3, 1/3 beginning one year from the date of grant.
F3 Granted under the 2017 Equity and Performance Incentive Plan; option is generally exercisable in annual increments of 1/3, 1/3, 1/3 beginning one year from the date of grant.